Should You Buy Bio-Rad Laboratories Stock After Its 50% Fall This Year?
Bio-Rad Laboratories stock (NYSE: BIO), a life science research and clinical diagnostic products company, has seen a 48% fall this year, significantly underperforming the broader S&P500 index, down 24%. However,…